Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4Breast 1

Conditions

Breast Neoplasms 138Prostatic Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 10Motor Activity 8Ovarian Neoplasms 7Gastrointestinal Neoplasms 7Neoplasms 5Uterine Cervical Neoplasms 4Sarcoma 4Lymphoma 4Endometrial Neoplasms 4Depression 4Pain 3Hereditary Breast and Ovarian Cancer Syndrome 3Fatigue 3Colonic Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Anxiety Disorders 3Vomiting 2Thyroid Neoplasms 2Neoplasm Metastasis 2Melanoma 2Leukemia 2Hodgkin Disease 2Head and Neck Neoplasms 2Communication 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2

Interventions

Nivolumab 2Cyclophosphamide 2tislelizumab 1spartalizumab 1pembrolizumab 1montanide ISA 51 1glembatumumab vedotin 1fludarabine phosphate 1entinostat 1cemiplimab 1Toll-Like Receptor 1 1Surveys and Questionnaires 1Specimen Handling 1Rose Bengal 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Interleukin-13 1Focus Groups 1Fluorodeoxyglucose F18 1Cryosurgery 1CTLA-4 Antigen 1CR011-vcMMAE 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Surveys and Questionnaires × Breast × Clear all
NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Institut Curie

Phase NA Completed
128 enrolled
BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡